Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Medicine Center of Excellence, |
RCV000171527 | SCV000221726 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
Gene |
RCV000171527 | SCV000748598 | pathogenic | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 30055037, 27124789, 33101984, 31130284) |
Ce |
RCV000171527 | SCV002545447 | pathogenic | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | LAMA2: PVS1, PM2 |
Revvity Omics, |
RCV000171527 | SCV003829183 | likely pathogenic | not provided | 2022-12-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004567375 | SCV005059875 | pathogenic | Merosin deficient congenital muscular dystrophy | 2024-03-19 | criteria provided, single submitter | clinical testing |